subject: UMLS:C5666986

subject_name: NKp46/CD16-based CD123-targeted NK Cell Engager SAR443579

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5666986

object_name: acute myeloid leukemia

tested_intervention: unsure


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:66903

subject_name: Vismodegib


subject: CHEBI:66903


subject: UMLS:C3658170

object_name: psoriasis


subject: UMLS:C2987349

subject_name: Prohibitin-Targeting Peptide 1

object_name: prostate carcinoma

tested_intervention: yes


subject: UMLS:C2987349

object_name: prostate cancer


subject: CHEBI:3219

subject_name: Bupropion

object_name: bipolar depression


subject: CHEBI:3219

object_name: Schizophrenia and related disorders


subject: CHEBI:3766

subject_name: Clozapine


subject: CHEBI:3766

object_name: endogenous depression


subject: CHEBI:3766

object_name: major depressive disorder


subject: CHEBI:3766


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:60799

subject_name: Esketamine

object_name: bipolar disorder


subject: CHEBI:60799


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:9123


subject: CHEBI:9123


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:9943


subject: CHEBI:231425

subject_name: tolvaptan

object_name: cardiomyopathy


subject: UMLS:C5447416

subject_name: Lindera obtusiloba Extract

object_name: non-small cell lung carcinoma


subject: UNII:760I9WM792

subject_name: Lasmiditan

object_name: Acute migraine


subject: UMLS:C2700142

subject_name: Vaccinia Virus DD-CDSR

object_name: liver cancer


subject: UMLS:C2700142

object_name: liver neoplasm


subject: UMLS:C2700142

object_name: Adult Liver Carcinoma


subject: UMLS:C2700142

object_name: liver carcinoma


subject: UMLS:C2700142

object_name: Childhood Breast Carcinoma


subject: UMLS:C2700142

object_name: breast carcinoma


subject: UMLS:C2700142

object_name: breast cancer


subject: UMLS:C2700142

object_name: colorectal cancer


subject: UMLS:C2700142

object_name: colorectal carcinoma


subject: UMLS:C2700142

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2700142

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2700142

object_name: pancreatic adenocarcinoma


subject: UMLS:C2700142

object_name: melanoma


subject: CHEBI:132922

object_name: sciatica


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: PUBCHEM.COMPOUND:11963629

subject_name: ferryl iron

object_name: Anemia in ovarian carcinoma


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Depressed mood


subject: UMLS:C1881373

object_name: Cancer patients and suicide and depression


subject: UMLS:C1881373

object_name: Depressed - symptom


subject: UMLS:C1881373

object_name: Depression, CTCAE


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: CHEBI:18332


subject: CHEBI:18332


subject: MESH:C000613429

subject_name: FluMist

object_name: influenza


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C5204604

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: rectal neoplasm


subject: PUBCHEM.COMPOUND:92043599

object_name: gastric neoplasm


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: Body Composition


subject: CHEBI:8378

subject_name: Prednisolone

object_name: hemangioma


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: inflammatory bowel disease 1


subject: CHEBI:38545

object_name: Crohn disease


subject: CHEBI:38545

object_name: Crohn's ileocolitis


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Restless legs


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:16494

subject_name: thioctic acid


subject: UMLS:C1541530

object_name: Advanced Prostate Adenocarcinoma


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: head and neck disorder


subject: CHEBI:172923

object_name: Parotid Gland Pleomorphic Adenoma


subject: CHEBI:172923

object_name: Warthin tumor


subject: CHEBI:172923

object_name: thyroid disease


subject: CHEBI:172923

object_name: reported prior thyroid disease (history)


subject: CHEBI:8382

subject_name: Prednisone

object_name: Homologous Recombination Deficiency


subject: CHEBI:231614

subject_name: Nivolumab

object_name: colon adenoma


subject: CHEBI:231614

object_name: MLH1 Gene Mutation


subject: CHEBI:231614

object_name: MSH2 Gene Mutation


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: GTOPDB:4975

object_name: pancreatitis


subject: GTOPDB:4975

object_name: Pancreatitis, CTCAE 5.0


subject: GTOPDB:4975

object_name: Pancreatitis, CTCAE 3.0


subject: GTOPDB:4975

object_name: pancreas disorder


subject: GTOPDB:4975

object_name: biliary tract disorder


subject: GTOPDB:4975

object_name: bile duct disorder


subject: GTOPDB:4975

object_name: gallbladder disorder


subject: UMLS:C0085295


subject: UMLS:C0085295


subject: UMLS:C0085295


subject: UMLS:C0085295


subject: UMLS:C0085295


subject: UMLS:C0085295


subject: UMLS:C0085295


subject: UMLS:C2983956

subject_name: Human Interleukin-10 (Nonglycosylated)


subject: UMLS:C2983956


subject: UMLS:C2983956


subject: UMLS:C2983956


subject: UMLS:C2983956


subject: UMLS:C2983956


subject: UMLS:C2983956


subject: UMLS:C1522550

subject_name: Recombinant Interleukin-10


subject: UMLS:C1522550


subject: UMLS:C1522550


subject: UMLS:C1522550


subject: UMLS:C1522550


subject: UMLS:C1522550


subject: UMLS:C1522550


subject: PUBCHEM.COMPOUND:71475145

subject_name: Amylase

object_name: Pancreatic fistula


subject: PUBCHEM.COMPOUND:71475145

object_name: Pancreatic Fistula, CTCAE


subject: UMLS:C0002712

subject_name: amylase


subject: UMLS:C0002712


subject: CHEBI:231491


subject: CHEBI:231491


subject: UNII:SCI18J406O

subject_name: C-REACTIVE PROTEIN


subject: UNII:SCI18J406O


subject: CHEBI:59527

object_name: Closed fracture of ankle


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: pustulosis palmaris et plantaris


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: UMLS:C2267018

subject_name: Bisphosphonate [EPC]

object_name: osteoporosis


subject: UMLS:C2267018

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C2267018

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C2267018

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C5447414

subject_name: JAK2 Inhibitor TQ05105

object_name: myelofibrosis


subject: UNII:832663U2NB

subject_name: Apararenone

object_name: diabetic kidney disease


subject: UMLS:C5566015


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: cocaine use disorder


subject: CHEBI:8228

object_name: alcohol abuse


subject: CHEBI:8228

object_name: alcohol dependence


subject: CHEBI:6121

subject_name: Ketamine

object_name: diabetic neuropathy


subject: CHEBI:3757

subject_name: Clonidine


subject: CHEBI:3756

subject_name: Clonazepam

object_name: Recurrent febrile convulsion


subject: UMLS:C2586540

subject_name: AdreView

object_name: cardiomyopathy


subject: UMLS:C2586540

object_name: heart failure


subject: UMLS:C2586540

object_name: Heart Failure, CTCAE


subject: UMLS:C1524094

subject_name: Recombinant Cytokines

object_name: HIV infection


subject: UMLS:C1524094

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C1524094

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C0079189

subject_name: cytokine


subject: UMLS:C0079189


subject: UMLS:C0079189


subject: CHEBI:73823

subject_name: Arg-Val


subject: CHEBI:73823


subject: CHEBI:73823


subject: PUBCHEM.COMPOUND:335257

subject_name: RV


subject: PUBCHEM.COMPOUND:335257


subject: PUBCHEM.COMPOUND:335257


subject: UMLS:C4053619

object_name: Angioimmunoblastic T-cell lymphoma refractory


subject: UMLS:C4053619

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: UMLS:C4053619

object_name: Refractory Grade 3a Follicular Lymphoma


subject: UMLS:C4053619

object_name: Refractory Grade 1 Follicular Lymphoma


subject: UMLS:C4053619

object_name: Refractory Grade 2 Follicular Lymphoma


subject: UMLS:C4053619

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UMLS:C4053619

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C4053619

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C4053619

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UMLS:C4053619

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UMLS:C4053619

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C4053619

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C4053619

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C4053619

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C4053619

object_name: Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C4053619

object_name: Mycosis fungoides stage III


subject: UMLS:C4053619

object_name: Stage IB Mycosis Fungoides AJCC v7


subject: UMLS:C4053619

object_name: Mycosis fungoides stage II


subject: UMLS:C4053619

object_name: Mycosis fungoides stage IV


subject: UMLS:C4053619

object_name: Mycosis fungoides recurrent


subject: CHEBI:231679

subject_name: ipilimumab

object_name: endometrial carcinoma


subject: CHEBI:231679

object_name: suppressor of tumorigenicity 3


subject: CHEBI:231679

object_name: cervical carcinoma


subject: DRUGBANK:DB18189

subject_name: AGuIX

object_name: Pancreatic carcinoma non-resectable


subject: DRUGBANK:DB18189

object_name: Advanced Pancreatic Adenocarcinoma


subject: DRUGBANK:DB18189

object_name: pancreatic ductal adenocarcinoma


subject: DRUGBANK:DB18189

object_name: non-small cell lung carcinoma


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: primary cerebellar degeneration


subject: CHEBI:8772

subject_name: Raloxifene

object_name: Alzheimer disease type 1


subject: CHEBI:8772

object_name: Alzheimer disease


subject: UMLS:C4722395

subject_name: Anti-CD38 Monoclonal Antibody

object_name: plasma cell myeloma


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: lung adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:31859

subject_name: Modafinil

object_name: Apathy


subject: CHEBI:31859

object_name: On examination - apathetic


subject: CHEBI:31859


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: Psoriasis of scalp


subject: CHEBI:3077

subject_name: Betamethasone


subject: UNII:01KC87F8FE

object_name: grade III glioma


subject: PR:000010011

subject_name: lysosomal-trafficking regulator


subject: PR:000010011

object_name: glioblastoma


subject: PR:000010011

object_name: Brain Stem Glioblastoma


subject: PR:000010011

object_name: glioma susceptibility 1


subject: PR:000003655


subject: PR:000003655


subject: PR:000003655


subject: PR:000003655


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: intrahepatic cholangiocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: PR:000005503


subject: PUBCHEM.COMPOUND:74380454

subject_name: Volixibat

object_name: intrahepatic cholestasis of pregnancy


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: neurotoxicity


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:8988

object_name: esophageal squamous cell carcinoma


subject: UMLS:C4287737

object_name: Childhood Solid Neoplasm


subject: UMLS:C4287737

object_name: Adult Solid Neoplasm


subject: UMLS:C4287737

object_name: Solid Neoplasm


subject: UMLS:C4287737

object_name: non-small cell lung carcinoma


subject: UMLS:C4287737

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4287737

object_name: clear cell renal carcinoma


subject: UMLS:C4287737

object_name: renal cell adenocarcinoma


subject: UMLS:C4287737

object_name: renal cell carcinoma


subject: UMLS:C4287737

object_name: triple-negative breast carcinoma


subject: UMLS:C4287737

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:132209614


subject: PUBCHEM.COMPOUND:132209614


subject: PUBCHEM.COMPOUND:132209614


subject: PUBCHEM.COMPOUND:132209614


subject: PUBCHEM.COMPOUND:132209614


subject: PUBCHEM.COMPOUND:132209614


subject: PUBCHEM.COMPOUND:132209614


subject: PUBCHEM.COMPOUND:132209614


subject: PUBCHEM.COMPOUND:132209614


subject: PUBCHEM.COMPOUND:132209614


subject: CHEBI:404903

subject_name: Ertapenem

object_name: Acute appendicitis NOS (disorder)


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: cancer


subject: CHEBI:73604

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:73604

object_name: Embolism, Tumor


subject: CHEBI:73604

object_name: Neoplasm Metastasis


subject: CHEBI:73604

object_name: Metastatic Lesion


subject: CHEBI:73604

object_name: breast neoplasm


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:9014

subject_name: Salsalate

object_name: arteriosclerosis disorder


subject: CHEBI:9014

object_name: atherosclerosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: panuveitis


subject: CHEBI:41879

object_name: intermediate uveitis


subject: CHEBI:41879

object_name: posterior uveitis


subject: CHEBI:91899

object_name: ASTHMA STABLE


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:80630

subject_name: Irinotecan

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:80630

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:80630

object_name: Metastatic Unresectable Gastric Adenocarcinoma


subject: CHEBI:80630

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C3827174

object_name: neoplastic meningitis


subject: CHEBI:8499

subject_name: Propranolol

object_name: Fetal or neonatal effect of induction of labor


subject: PUBCHEM.COMPOUND:137319706

subject_name: Orforglipron

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:137319706

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:7ZW40D021M

subject_name: ORFORGLIPRON


subject: UNII:7ZW40D021M


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: atopic eczema


subject: CHEBI:50648

object_name: dermatitis


subject: CHEBI:50648

object_name: Eczema, CTCAE


subject: UMLS:C1568660

object_name: Refractory Acute Leukemia


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: tic disorder


subject: RXCUI:220326

subject_name: Tis-U-Sol

object_name: nasopharyngeal neoplasm


subject: CHEBI:74705

subject_name: Met-Leu

object_name: no feeling or sensation of skin


subject: CHEBI:74705

object_name: Sensory Loss


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:27306

subject_name: vitamin B6

object_name: autism spectrum disorder


subject: UNII:2S27T3DSZ3

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:141754136

object_name: asthma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Plexosarcoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:41423

subject_name: Celecoxib

object_name: pain agnosia


subject: CHEBI:41423

object_name: Pain insensitivity


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: hereditary breast ovarian cancer syndrome


subject: UNII:6XC1PAD3KF

object_name: malignant epithelial tumor of ovary


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:30742

subject_name: macrogol

object_name: Post procedural constipation


subject: CHEBI:16646

subject_name: carbohydrate

object_name: fetus affected by Cesarean delivery


subject: CHEBI:16646

object_name: pregnancy related


subject: CHEBI:16646

object_name: Fetus in fetu


subject: CHEBI:4875

subject_name: Etanercept

object_name: COPD exacerbation


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PUBCHEM.COMPOUND:4474936

object_name: primary biliary cholangitis


subject: CHEBI:6960

subject_name: Moexipril


subject: CHEBI:8884

subject_name: Rocuronium

object_name: benign prostatic hyperplasia


subject: CHEBI:8884

object_name: kidney disorder


subject: CHEBI:2914

subject_name: Atracurium


subject: CHEBI:2914


subject: CHEBI:6958

subject_name: Mivacurium


subject: CHEBI:6958


subject: UNII:RFG3GJ6251

object_name: acute myeloid leukemia by FAB classification


subject: UNII:RFG3GJ6251

object_name: acute myeloid leukemia


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: hemangioma


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Atypical behavior


subject: CHEBI:46195

object_name: vascular dementia


subject: CHEBI:46195

object_name: Alzheimer disease


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: Presenile dementia


subject: UMLS:C2917659

object_name: dementia


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:66964

subject_name: Dronabinol


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:51817

subject_name: Temocillin

object_name: bacterial urinary tract infection


subject: CHEBI:51817

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:4026

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:4026

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:4026

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:4026

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:4026

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: CHEBI:4026

object_name: fallopian tube serous adenocarcinoma


subject: CHEBI:4026

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEBI:4026

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:4026

object_name: ovarian clear cell adenocarcinoma


subject: CHEBI:4026

object_name: ovarian serous adenocarcinoma


subject: CHEBI:4026

object_name: Primary mucinous adenocarcinoma of ovary


subject: CHEBI:4026

object_name: ovarian mucinous adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: undifferentiated ovarian carcinoma


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: ovarian endometrioid adenocarcinoma


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:2NDX4B6N8F

subject_name: HA 22

object_name: leukemia


subject: UNII:2NDX4B6N8F

object_name: childhood leukemia


subject: UMLS:C2346797


subject: UMLS:C2346797


subject: UNII:9JH486CZ13

subject_name: Molidustat

object_name: kidney disorder


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: liver carcinoma


subject: UMLS:C2828372


subject: PR:000022848

subject_name: guanosine-inosine kinase

object_name: malaria


subject: UniProtKB:P0AEW6

subject_name: INGK_ECOLI Guanosine-inosine kinase (sprot)


subject: UMLS:C0003299

subject_name: Antiepileptic Agents

object_name: intellectual disability


subject: CHEBI:40594


subject: CHEBI:40594

object_name: epilepsy


subject: UMLS:C0887457

subject_name: Cystamine Dihydrochloride


subject: UMLS:C0887457


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: liver cirrhosis


subject: CHEBI:5801

object_name: Muscle spasm


subject: CHEBI:5801

object_name: Hyperkinesia


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Irreversible pulpitis


subject: UMLS:C0106660

object_name: Blood Clot


subject: UMLS:C0106660

object_name: thrombosis


subject: UMLS:C0106660

object_name: Thrombosis of blood vessel


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: pediatric lymphoma


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: UNII:30R67U9KYS


subject: CHEBI:90929

subject_name: Lesinurad

object_name: gout


subject: CHEBI:78543

subject_name: Ponatinib

object_name: Malignant hepatobiliary neoplasms


subject: DRUGBANK:DB09106

subject_name: hetastarch

object_name: Total fluid volume increased


subject: UNII:958AQ7B6R1

subject_name: Eprotirome

object_name: Hypercholesterolemia


subject: CHEBI:9150

subject_name: Simvastatin

object_name: hepatitis B


subject: PUBCHEM.COMPOUND:22023730

subject_name: Ganaxolone

object_name: complex partial epilepsy


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Childhood Breast Carcinoma


subject: CHEBI:8884

object_name: breast carcinoma


subject: CHEBI:8884

object_name: breast cancer


subject: UMLS:C1571394

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:94187

subject_name: Givinostat


subject: CHEBI:31174

subject_name: Adapalene

object_name: Acne scar


subject: CHEBI:63450

subject_name: Masitinib

object_name: rheumatoid arthritis


subject: CHEBI:35739

subject_name: Pentetic acid

object_name: cystic fibrosis


subject: UMLS:C5707546

subject_name: Technetium Tc-99m DARPinG3

object_name: Malignant neoplasm of female breast


subject: UMLS:C4521107

object_name: Pre T-ALL


subject: UMLS:C4521107

object_name: Adult T Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE


subject: PUBCHEM.COMPOUND:166625217


subject: UMLS:C5782829

subject_name: ROPivacaine 0.2% injectable solution

object_name: ventricular septal defect


subject: UMLS:C5782829

object_name: Pain, Procedural


subject: UMLS:C5782829

object_name: atrial septal defect


subject: UNII:8D7B37T28G

subject_name: SATRAPLATIN

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: ureteral obstruction


subject: PUBCHEM.COMPOUND:18319735

object_name: Flank Pain, CTCAE


subject: PUBCHEM.COMPOUND:18319735

object_name: Flank pain


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: nasopharyngeal carcinoma


subject: UMLS:C5667079

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C5667079

object_name: non-small cell lung carcinoma


subject: CHEBI:15365

subject_name: Aspirin

object_name: thrombotic thrombocytopenic purpura


subject: CHEBI:15365

object_name: Thrombotic Thrombocytopenic Purpura, CTCAE


subject: UMLS:C4278755

object_name: diabetic kidney disease


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Hepatic decompensation


subject: CHEBI:3441

object_name: Advanced chronic liver disease


subject: UNII:9G2MP84A8W

object_name: common cold


subject: UNII:9G2MP84A8W

object_name: Acute Coryza


subject: GTOPDB:11125

object_name: Neoplasm of the gastrointestinal tract


subject: GTOPDB:11125

object_name: gastric adenocarcinoma


subject: GTOPDB:11125

object_name: colorectal adenocarcinoma


subject: UMLS:C5237827

subject_name: Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119


subject: UMLS:C5237827


subject: UMLS:C5237827


subject: CHEBI:135918

subject_name: Tucidinostat


subject: DRUGBANK:DB19248

subject_name: Bifidobacterium longum

object_name: Crohn disease


subject: CHEBI:177298

object_name: metastatic melanoma


subject: CHEBI:176844

subject_name: Niraparib


subject: UMLS:C2976397

object_name: glaucoma


subject: UMLS:C2976397

object_name: Glaucoma, CTCAE


subject: CHEBI:64816

object_name: male breast carcinoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Breast cancer stage II


subject: CHEBI:141969

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:141969

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:141969

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:141969

object_name: Childhood Breast Carcinoma


subject: CHEBI:141969

object_name: breast carcinoma


subject: CHEBI:141969

object_name: breast cancer


subject: CHEBI:141969


subject: CHEBI:141969

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:141969

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:141969

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: GTOPDB:12652

subject_name: magrolimab

object_name: large B-cell lymphoma


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: tinea pedis


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)

object_name: essential thrombocythemia


subject: UniProtKB:P47802

object_name: myelofibrosis


subject: PR:000010755


subject: PR:000010755


subject: UMLS:C4745069

subject_name: Anti-PVRIG Monoclonal Antibody COM701

object_name: ovarian cancer


subject: UMLS:C4745069

object_name: ovarian neoplasm


subject: UMLS:C4745069

object_name: ovarian carcinoma


subject: UMLS:C4745069

object_name: Recurrent ovarian cancer


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: coronary microvascular disorder


subject: UMLS:C3714803

object_name: arteriosclerosis disorder


subject: UMLS:C3714803

object_name: atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C5417984

subject_name: MEK Inhibitor HL-085

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417984

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:73345788

subject_name: SUROTOMYCIN

object_name: Clostridium difficile colitis


subject: PUBCHEM.COMPOUND:73345788

object_name: clostridium difficile infection


subject: UMLS:C4079995

subject_name: Surotomycin


subject: UMLS:C4079995


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Gaucher disease


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C1720919

subject_name: Zostavax

object_name: immune system disorder


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: influenza


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: Alzheimer disease type 1


subject: CHEBI:73024

object_name: Alzheimer disease


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:57589


subject: CHEBI:76842

object_name: staphylococcal pneumonia


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:8461

subject_name: Promethazine

object_name: Pruritus, CTCAE


subject: CHEBI:8461

object_name: Pruritus


subject: CHEBI:8461

object_name: pregnancy related


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: sickle cell disease


subject: CHEMBL.COMPOUND:CHEMBL4650520

subject_name: LEMZOPARLIMAB

object_name: plasma cell myeloma


subject: UMLS:C5235865


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Alzheimer Disease, Early Onset


subject: UMLS:C3714501

object_name: Cognitive impairment


subject: CHEBI:5931

subject_name: insulin human


subject: GTOPDB:13369


subject: GTOPDB:13369

object_name: T-cell large granular lymphocyte leukemia


subject: GTOPDB:13369

object_name: primary cutaneous T-cell lymphoma


subject: DRUGBANK:DB17165

object_name: Solid Neoplasm


subject: DRUGBANK:DB17165


subject: DRUGBANK:DB17165


subject: PR:000005679

subject_name: bifunctional coenzyme A synthase

object_name: Subcortical Vascular Dementia


subject: PR:000005679

object_name: brain small vessel disease 3


subject: PR:000011476

subject_name: cytosolic Fe-S cluster assembly factor NUBP1


subject: PR:000011476


subject: CHEBI:40279

subject_name: Allopurinol

object_name: chronic kidney disease


subject: CHEBI:40279

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:9150

subject_name: Simvastatin

object_name: stroke disorder


subject: CHEBI:9150

object_name: cerebrovascular disorder


subject: CHEBI:9150

object_name: Stroke (heart beat)


subject: CHEBI:9150

object_name: Stroke, CTCAE


subject: CHEBI:6704

subject_name: Mebendazole

object_name: hookworm infectious disease


subject: CHEBI:6704

object_name: ancylostomiasis


subject: PUBCHEM.COMPOUND:90488848


subject: GTOPDB:1331

subject_name: ACTH


subject: UMLS:C3539087

subject_name: ACTH and synthetic analog preparations


subject: CHEBI:3892

subject_name: Corticotropin


subject: CHEBI:27732

subject_name: Caffeine

object_name: cellulitis


subject: CHEBI:27732

object_name: cellulitis on exam (physical finding)


subject: UMLS:C0018284

subject_name: Growth Factor

object_name: shoulder impingement syndrome


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18

object_name: cervical polyp


subject: UNII:2X1K91UT6N

object_name: endometrium neoplasm


subject: UNII:2X1K91UT6N

object_name: prostate cancer


subject: UNII:2X1K91UT6N

object_name: prostate neoplasm


subject: UNII:2X1K91UT6N

object_name: rectal neoplasm


subject: UNII:2X1K91UT6N

object_name: anus neoplasm


subject: GTOPDB:8928

subject_name: pamrevlumab

object_name: interstitial lung disease 1


subject: GTOPDB:8928

object_name: interstitial lung disease 2


subject: CHEMBL.COMPOUND:CHEMBL2109377

subject_name: PAMREVLUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109377


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: prostate carcinoma


subject: CHEBI:231598


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:32682

subject_name: L-argininium

object_name: liver carcinoma


subject: CHEBI:32682

object_name: Klatskin Tumor


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:32262

subject_name: Trimetazidine hydrochloride


subject: CHEBI:32262


subject: CHEBI:94789

subject_name: Trimetazidine


subject: CHEBI:94789


subject: CHEBI:74947

subject_name: Thalidomide

object_name: myelofibrosis


subject: CHEBI:4717

subject_name: Droperidol

object_name: post operative nausea and vomiting


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Infant, Premature, Diseases


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:27470

subject_name: Folic acid

object_name: B-cell neoplasm


subject: CHEBI:71223

subject_name: Pralatrexate


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C5204487

subject_name: PI3K/mTOR Kinase Inhibitor WXFL10030390

object_name: Childhood Solid Neoplasm


subject: UMLS:C5204487

object_name: Adult Solid Neoplasm


subject: UMLS:C5204487

object_name: Solid Neoplasm


subject: CHEBI:6933

subject_name: Midodrine

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:6933

object_name: Abnormal left ventricular function


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Hemorrhagic Shock


subject: CHEBI:90001

object_name: TRAUMA/INJURY PROBLEM


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:36088


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: retroperitoneal sarcoma


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: CHEBI:74088


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR

object_name: Parkinson disease


subject: CHEBI:16112

subject_name: Chlorogenate

object_name: Advanced lung cancer


subject: UMLS:C5667035

subject_name: CDK9 Inhibitor PRT2527

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5667035

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5667035

object_name: Myelodysplasia


subject: UMLS:C5667035

object_name: adult acute myeloid leukemia


subject: UMLS:C5667035

object_name: childhood acute myeloid leukemia


subject: UMLS:C5667035

object_name: acute myeloid leukemia


subject: UMLS:C5667035

object_name: marginal zone lymphoma


subject: UMLS:C5667035

object_name: MALT lymphoma


subject: UMLS:C5667035

object_name: Richter syndrome


subject: UMLS:C5667035

object_name: T-Cell Lymphoma


subject: UMLS:C5667035

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: neonatal sepsis


subject: UNII:T42P99266K

object_name: Bacterial sepsis of newborn


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: UMLS:C0876134

subject_name: Prevnar

object_name: Immunosuppression


subject: UMLS:C0876134

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:156295

object_name: hyperphosphatemia


subject: CHEBI:156295

object_name: Serum phosphate concentrations above normal (finding)


subject: CHEBI:156295

object_name: Hyperphosphatemia, CTCAE


subject: UMLS:C4331950

object_name: Subarachnoid Hemorrhage, Spontaneous


subject: PUBCHEM.COMPOUND:11154555

subject_name: Cariprazine

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:11154555

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:11154555

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:11154555

object_name: Depression, CTCAE


subject: CHEBI:90933


subject: CHEBI:90933


subject: CHEBI:90933


subject: CHEBI:90933


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: kidney disorder


subject: PUBCHEM.COMPOUND:73151030

object_name: impaired renal function disease


subject: CHEBI:6015

subject_name: Isoflurane

object_name: septic shock


subject: CHEBI:141447

subject_name: Trp-Asn

object_name: West-Nile encephalitis


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: endogenous depression


subject: CHEBI:17650

object_name: major depressive disorder


subject: CHEBI:17650

object_name: anxiety disorder


subject: UMLS:C2987410

subject_name: Crystalline Genistein Formulation AXP107-11

object_name: esophageal adenocarcinoma


subject: UMLS:C2987410

object_name: lung adenocarcinoma


subject: UMLS:C2987410

object_name: cervical adenocarcinoma


subject: UMLS:C2987410

object_name: adenocarcinoma


subject: UMLS:C2987410

object_name: bile duct adenocarcinoma


subject: UMLS:C2987410

object_name: gastric adenocarcinoma


subject: CHEBI:65173

subject_name: Iloperidone


subject: CHEBI:65173


subject: UNII:2CQ8Y0B8XQ

object_name: kidney failure


subject: PUBCHEM.COMPOUND:2269

object_name: chronic asthma


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:233318

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:233318

object_name: Refractory acute myeloid leukemia


subject: UMLS:C5555665

subject_name: BRG1/BRM Inhibitor FHD-286


subject: UMLS:C5555665


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Recurrent disease


subject: UNII:4Z63YK6E0E

object_name: Global Relapse in Viscera


subject: UNII:4Z63YK6E0E

object_name: Global Relapse in Lymph Nodes


subject: UNII:4Z63YK6E0E

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UNII:4Z63YK6E0E

object_name: Global Relapse


subject: UNII:4Z63YK6E0E

object_name: Global Relapse in Skin


subject: UNII:4Z63YK6E0E

object_name: Global Relapse in Blood


subject: UNII:4Z63YK6E0E

object_name: Relapse multiple myeloma


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:3921

subject_name: Cromakalim

object_name: Headache


subject: CHEBI:3921

object_name: Headache, CTCAE


subject: CHEBI:3921

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:6436

subject_name: Levcromakalim


subject: CHEBI:6436


subject: CHEBI:6436


subject: UMLS:C0244960


subject: UMLS:C0244960


subject: UMLS:C0244960


subject: CHEBI:18248

subject_name: Iron

object_name: preeclampsia


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:27470

subject_name: Folic acid


subject: UMLS:C3659294

object_name: Wet age-related macular degeneration


subject: CHEBI:16302

object_name: Community-Acquired Pneumonia


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Childhood Breast Carcinoma


subject: CHEBI:50692

object_name: breast carcinoma


subject: CHEBI:50692

object_name: breast cancer


subject: UNII:6897GXD6OE

object_name: Heart Failure, CTCAE


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Malignant neoplasm of female breast


subject: UNII:2AW48LAZ4I

subject_name: IMETELSTAT SODIUM

object_name: Myelodysplasia


subject: UNII:2AW48LAZ4I

object_name: acute myeloid leukemia by FAB classification


subject: UNII:2AW48LAZ4I

object_name: acute myeloid leukemia


subject: UNII:F60NE4XB53

subject_name: imetelstat


subject: UNII:F60NE4XB53


subject: UNII:F60NE4XB53


subject: UMLS:C0879396

object_name: lung cancer


subject: UMLS:C0879396

object_name: lung neoplasm


subject: UMLS:C0879396

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: lymphoproliferative syndrome


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: hemorrhoid


subject: UNII:L500PR95QA

object_name: Hemorrhoids, CTCAE 3.0


subject: UNII:L500PR95QA

object_name: Hemorrhoids, CTCAE 5.0


subject: CHEBI:75984

subject_name: Flecainide

object_name: Surgical procedure finding


subject: UNII:G04B77F772

subject_name: BATABULIN SODIUM


subject: UNII:G04B77F772


subject: UNII:G04B77F772


subject: UMLS:C1523985

subject_name: Batabulin Sodium


subject: UMLS:C1523985


subject: UMLS:C1523985


subject: DRUGBANK:DB10653

subject_name: Cashew

object_name: Allergy to shrimp


subject: DRUGBANK:DB10653

object_name: food allergy


subject: UMLS:C0873019

subject_name: Berberine hydrochloride

object_name: colorectal adenoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Leigh syndrome


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: psoriatic arthritis


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: CHEBI:23359

subject_name: colchicine

object_name: kidney failure


subject: CHEBI:23359

object_name: Renal Failure, CTCAE


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: inflammatory breast carcinoma


subject: UMLS:C0304229

subject_name: Experimental drug

object_name: cancer


subject: UMLS:C0304229

object_name: neoplasm


subject: UMLS:C0109265

subject_name: chamomile flower oil

object_name: Seborrhoeic blepharitis


subject: UMLS:C5416832


subject: CHEBI:77590

subject_name: Armodafinil

object_name: malignant glioma


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:47426

subject_name: Furosemide

object_name: cardiorenal syndrome type 1


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: secondary hyperparathyroidism


subject: PUBCHEM.COMPOUND:157010068

subject_name: Calcium citrate


subject: UNII:MLM29U2X85


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: Acute Ischemic Stroke


subject: PR:000017019

object_name: Ischemic stroke


subject: CHEBI:211030

subject_name: IV T


subject: CHEBI:211030


subject: CHEBI:73614

subject_name: Met-Thr


subject: CHEBI:73614


subject: CHEBI:33361

subject_name: meitnerium atom


subject: CHEBI:33361


subject: PR:000010231

subject_name: malonyl-CoA-acyl carrier protein transacylase, mitochondrial


subject: PR:000010231


subject: CHEBI:52717

subject_name: Bortezomib

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C1512053

subject_name: Adriacin

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C1512053

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: migraine


subject: CHEBI:4636

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:46295

subject_name: Vardenafil

object_name: Unable to perform sex


subject: CHEBI:135622

subject_name: Besifloxacin

object_name: senile cataract


subject: CHEBI:135622

object_name: microbial disease


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: Helicobacter pylori infection


subject: UMLS:C3272840

subject_name: meningococcal polysaccharide vaccine (MPSV4)

object_name: Meningitis, Meningococcal, Serogroup B


subject: UMLS:C2960908

subject_name: Meningococcal vaccine component


subject: UMLS:C0675788

subject_name: Eovist

object_name: prostate carcinoma


subject: UMLS:C0675788

object_name: prostate cancer


subject: CHEBI:74705

subject_name: Met-Leu

object_name: acute pancreatitis


subject: CHEBI:74705

object_name: Intra-Abdominal Hypertension


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:2668

subject_name: Amlodipine

object_name: focal dystonia


subject: DRUGBANK:DB10418

subject_name: Blatella germanica

object_name: asthma


subject: DRUGBANK:DB10418

object_name: Atopic rhinitis


subject: DRUGBANK:DB10418

object_name: perennial allergic rhinitis


subject: UMLS:C0440016

subject_name: Allergenic extract


subject: UMLS:C5399714

subject_name: Allergenic Extract [APC]


subject: UMLS:C5399714


subject: UMLS:C5399714


subject: PUBCHEM.COMPOUND:71306410

subject_name: Azarga

object_name: glaucoma


subject: PUBCHEM.COMPOUND:71306410

object_name: Glaucoma, CTCAE


subject: CHEBI:6444

subject_name: Levorphanol

object_name: chronic pain (diagnosis)


subject: CHEBI:6444

object_name: Chronic pain


subject: GTOPDB:9107

subject_name: cabiralizumab

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: GTOPDB:9107

object_name: stage IV pancreatic cancer


subject: UNII:5FJL6W0640

subject_name: CABIRALIZUMAB


subject: UNII:5FJL6W0640


subject: UMLS:C4085968


subject: UMLS:C4085968


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: endocrine exophthalmos


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UMLS:C5205482

subject_name: HDAC Class I/IIb Inhibitor HG146

object_name: plasma cell myeloma


subject: UMLS:C2606533

subject_name: Hemospan

object_name: Critical lower limb ischemia


subject: UMLS:C2606533

object_name: aneurysm


subject: UMLS:C3495434

subject_name: hydroxyethyl starch 130-0.4


subject: UMLS:C3495434


subject: DRUGBANK:DB10447

subject_name: Saccharomyces cerevisiae

object_name: vulvovaginal candidiasis


subject: UNII:6K6L7E3F1L

subject_name: Gefapixant

object_name: interstitial cystitis


subject: UNII:6K6L7E3F1L

object_name: Painful Bladder Syndrome


subject: MESH:D014613

subject_name: Vaccines, Attenuated

object_name: rubella


subject: MESH:D014613

object_name: chickenpox


subject: MESH:D014613

object_name: measles


subject: MESH:D014613

object_name: mumps


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: urothelial carcinoma


subject: CHEBI:63584

object_name: transitional cell carcinoma


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: alcohol dependence


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:9AG41L3AOQ

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UNII:9AG41L3AOQ

object_name: PSA Level Greater than Fifty


subject: UMLS:C1312686

subject_name: Femarelle

object_name: Hot Flashes, CTCAE


subject: UMLS:C1312686

object_name: Hot flashes


subject: DRUGBANK:DB14277

subject_name: Tripterygium wilfordii whole

object_name: focal segmental glomerulosclerosis


subject: DRUGBANK:DB14277

object_name: proteinuria


subject: DRUGBANK:DB14277

object_name: Proteinuria of undiagnosed cause


subject: DRUGBANK:DB14277

object_name: Proteinuria, CTCAE 3.0


subject: DRUGBANK:DB14277

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:73666

subject_name: Thr-Trp


subject: CHEBI:73666


subject: CHEBI:73666


subject: CHEBI:73666


subject: CHEBI:73666


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Locally Advanced Cervical Adenocarcinoma


subject: CHEBI:31355

object_name: Locally Advanced Cervical Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: Locally Advanced Cervical Adenosquamous Carcinoma


subject: CHEBI:31355

object_name: Stage IVA Cervical Cancer FIGO 2018


subject: CHEBI:31355

object_name: Stage IIIA Cervical Cancer FIGO 2018


subject: CHEBI:31355

object_name: Stage IIIC2 Cervical Cancer FIGO 2018


subject: CHEBI:31355

object_name: Stage IIIC1 Cervical Cancer FIGO 2018


subject: CHEBI:31355

object_name: Stage IIIB Cervical Cancer FIGO 2018


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:132830

subject_name: delta-elemene

object_name: Refractory Glioblastoma


subject: PUBCHEM.COMPOUND:10583

subject_name: (-)-cis-beta-Elemene


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: PUBCHEM.COMPOUND:71301236

object_name: type 2 diabetes mellitus


subject: UMLS:C3850864


subject: UMLS:C5555610

subject_name: PKMYT1 Inhibitor RP-6306

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: arthritis


subject: CHEBI:50790

object_name: Arthritis, CTCAE


subject: CHEBI:50790

object_name: breast neoplasm


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:2704

subject_name: Anastrozole


subject: CHEBI:2704


subject: UMLS:C4725031

subject_name: Adenosine A2B Receptor Antagonist PBF-1129

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UMLS:C4725031

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C4725031

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C4725031

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C4725031

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:39585

subject_name: Carbidopa

object_name: Cannabis use disorder


subject: CHEBI:149837

subject_name: Alisporivir

object_name: hepatobiliary disorder


subject: CHEBI:149837

object_name: liver disorder


subject: UMLS:C1567950

subject_name: alisporivir


subject: UMLS:C1567950


subject: UMLS:C3248394

subject_name: Injection, ipilimumab, 1 mg administered

object_name: melanoma


subject: UMLS:C3248394

object_name: Unresectable Melanoma


subject: UMLS:C5203457

subject_name: Ipilimumab Liquid Injection


subject: UMLS:C5203457


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UMLS:C3827149


subject: UNII:NU90V55F8I

subject_name: Sarilumab


subject: UNII:NU90V55F8I


subject: CHEBI:18258

subject_name: Liothyronine

object_name: euthyroid sick syndrome


subject: UMLS:C0010826

subject_name: Cytomel


subject: GTOPDB:11827

subject_name: telitacicept

object_name: thrombocytopenia


subject: GTOPDB:11827

object_name: connective tissue disorder


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: CHEMBL.COMPOUND:CHEMBL5095293


subject: UMLS:C5238006


subject: UMLS:C5238006


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Tissue perfusion measure


subject: DRUGBANK:DB11360

subject_name: Lactobacillus plantarum

object_name: Signs and Symptoms, Respiratory


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Ischemic reperfusion injury


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:60802

subject_name: ropivacaine

object_name: renal carcinoma


subject: CHEBI:60802

object_name: kidney neoplasm


subject: CHEBI:60802

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:4456137

subject_name: Epothilone B

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:4456137

object_name: prostate neoplasm


subject: CHEBI:31550

subject_name: Patupilone


subject: CHEBI:31550


subject: CHEBI:74067

subject_name: Ile-Ile

object_name: Ewing sarcoma


subject: PR:000001822

subject_name: MHC class II histocompatibility antigen gamma chain


subject: PR:000007904


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Hemorrhage


subject: CHEBI:67272

subject_name: Perifosine

object_name: leukemia


subject: CHEBI:67272

object_name: childhood leukemia


subject: CHEBI:15365

subject_name: Aspirin

object_name: Bone fracture


subject: CHEBI:15365

object_name: Fractured


subject: CHEBI:15365

object_name: cancer


subject: UMLS:C4722508

subject_name: Polycap

object_name: cardiovascular disorder


subject: UMLS:C4722508


subject: UMLS:C4722508


subject: UMLS:C4722508


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C5667079

subject_name: Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1

object_name: Childhood Breast Carcinoma


subject: UMLS:C5667079

object_name: breast carcinoma


subject: UMLS:C5667079

object_name: breast cancer


subject: PUBCHEM.COMPOUND:2269

object_name: Obstetric Labor Complications


subject: PUBCHEM.COMPOUND:2269

object_name: Pregnancy in Obesity


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: MESH:C496822

subject_name: xuezhikang

object_name: Dyslipidemia


subject: CHEBI:231891


subject: CHEBI:73044

subject_name: Lumiracoxib

object_name: Arthralgia


subject: CHEBI:73044

object_name: Arthralgia, CTCAE


subject: CHEBI:73044

object_name: chronic kidney disease


subject: CHEBI:73044

object_name: Chronic uremia


subject: CHEBI:8707

subject_name: Quetiapine

object_name: substance-related disorder


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Other and unspecified agents primarily acting on the respiratory system causing adverse effects in therapeutic use


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:85990

object_name: Recurrent Glioblastoma


subject: UMLS:C5814332

object_name: phenylketonuria


subject: UMLS:C5814332

object_name: classic phenylketonuria


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:51799

subject_name: Imipenem

object_name: bacterial infectious disease


subject: CHEBI:91950


subject: CHEBI:3697

subject_name: Cilastatin


subject: UMLS:C5238980

subject_name: Kanitinib

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:11217464

subject_name: HYDROXYTYROSOL

object_name: cardiovascular disorder


subject: CHEBI:70839

subject_name: Dasatinib

object_name: HIV infection


subject: CHEBI:70839

object_name: Problem of aging


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:31348

subject_name: Capecitabine

object_name: outcomes general quality of life


subject: CHEBI:31348

object_name: Perceived quality of life


subject: CHEBI:31348

object_name: Good quality of life


subject: MESH:C541363

object_name: neoplasm


subject: CHEBI:177597

subject_name: Fispemifene

object_name: sexual disorder


subject: CHEBI:177597

object_name: physiological sexual disorder


subject: CHEBI:177597

object_name: hypogonadotropic hypogonadism


subject: CHEBI:177597

object_name: impotence


subject: CHEBI:177597

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:177597

object_name: Erectile dysfunction


subject: UMLS:C1880780

subject_name: fispemifene


subject: UMLS:C1880780


subject: UMLS:C1880780


subject: UMLS:C1880780


subject: UMLS:C1880780


subject: UMLS:C1880780


subject: CHEBI:45783

subject_name: Imatinib

object_name: squamous cell carcinoma


subject: CHEBI:231683

subject_name: Anakinra

object_name: high grade B-cell lymphoma


subject: CHEBI:231683

object_name: diffuse large B-cell lymphoma


subject: CHEBI:231683

object_name: Progressive cGVHD


subject: CHEBI:231683

object_name: Progressive Disease


subject: CHEBI:231683

object_name: Progressive Neoplastic Disease


subject: CHEBI:231683

object_name: IMWG Progressive Disease


subject: CHEBI:231683

object_name: irPD (Immune-Related Response Criteria)


subject: CHEBI:231683

object_name: Global Progressive Disease in Viscera


subject: CHEBI:231683

object_name: RECIL PD


subject: CHEBI:231683

object_name: Global Progressive Disease in Skin


subject: CHEBI:231683

object_name: Global Progressive Disease


subject: CHEBI:231683

object_name: Global Progressive Disease in Lymph Nodes


subject: CHEBI:231683

object_name: Global Progressive Disease in Blood


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:31718

subject_name: Ioxaglic acid

object_name: coronary artery disorder


subject: CHEBI:31718

object_name: coronary atherosclerosis


subject: UMLS:C5206943

subject_name: Radspherin

object_name: ovarian cancer


subject: UMLS:C5206943

object_name: ovarian neoplasm


subject: UMLS:C5206943

object_name: ovarian carcinoma


subject: UMLS:C5206943

object_name: peritoneal carcinomatosis


subject: CHEBI:15940

subject_name: Niacin

object_name: Inflammation


subject: CHEBI:63453

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Charcot-Marie-Tooth disease type 1A


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C3273458

object_name: melanoma


subject: UNII:1D2T74921W

subject_name: NAFAMOSTAT MESYLATE

object_name: Sepsis


subject: UNII:1D2T74921W

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:9868041


subject: PUBCHEM.COMPOUND:9868041


subject: CHEBI:135466

subject_name: Nafamostat


subject: CHEBI:135466


subject: UMLS:C0207682

subject_name: nafamostat mesilate


subject: UMLS:C0207682


subject: PUBCHEM.COMPOUND:187888

subject_name: Endostatins

object_name: Refractory Neoplasm


subject: PUBCHEM.COMPOUND:187888

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297747

subject_name: ENDOSTATIN


subject: CHEMBL.COMPOUND:CHEMBL4297747


subject: UMLS:C0534628


subject: UMLS:C0534628


subject: UMLS:C1705207

subject_name: Endostar


subject: UMLS:C1705207


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: nephrolithiasis, calcium oxalate


subject: CHEBI:5778

object_name: nephrolithiasis


subject: CHEBI:3654

subject_name: Chlorthalidone


subject: CHEBI:3654


subject: UMLS:C0021735

subject_name: Viraferon

object_name: liver carcinoma


subject: CHEBI:229762

subject_name: Eltanexor

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:229762

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:229762

object_name: Refractory acute myeloid leukemia


subject: CHEBI:229762

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C3536851

subject_name: Calcium Channel Blocker [EPC]

object_name: hypertension


subject: UMLS:C3536851

object_name: Hypertension, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2109103

subject_name: BERTILIMUMAB

object_name: Pemphigoid


subject: UMLS:C5238160

subject_name: Bertilimumab


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: viral pneumonia


subject: CHEBI:33375

subject_name: Gadolinium

object_name: myocardial ischemia


subject: CHEBI:33375

object_name: coronary atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: GTOPDB:3711

object_name: Glucose^1.5H post dose glucagon


subject: GTOPDB:3711

object_name: glucose measurement


subject: GTOPDB:3711

object_name: Pregnant


subject: UNII:FS1N52VS3S


subject: UNII:FS1N52VS3S


subject: UNII:FS1N52VS3S


subject: UMLS:C1721258


subject: UMLS:C1721258


subject: UMLS:C1721258


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Gonadotropin-Resistant Ovary Syndrome


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:46217

subject_name: L-alanine residue

object_name: Androgen excess


subject: CHEBI:46217


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:158283


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16449


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:17549


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:27432


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:16977


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: CHEBI:7986


subject: CHEBI:146207

subject_name: palytoxin


subject: CHEBI:146207


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: Constipation


subject: PUBCHEM.COMPOUND:66964417

object_name: Constipation, CTCAE


subject: PUBCHEM.COMPOUND:66964417

object_name: anus disorder


subject: PUBCHEM.COMPOUND:66964417

object_name: anal fissure on exam (physical finding)


subject: PUBCHEM.COMPOUND:66964417

object_name: Anal Fissure, CTCAE


subject: PUBCHEM.COMPOUND:66964417

object_name: Anal fissure


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: CHEBI:30742

subject_name: macrogol


subject: CHEBI:30742


subject: CHEBI:30742


subject: CHEBI:30742


subject: PR:000013538

object_name: intervertebral disk degenerative disorder


subject: PR:000013538

object_name: lumbar disk degenerative disorder


subject: PR:000013538

object_name: Degenerative spondylolisthesis


subject: PR:000013538

object_name: spinal stenosis


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Locally Advanced Cervical Carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:85995

subject_name: lenvatinib mesylate

object_name: Solid Neoplasm


subject: UMLS:C2606791


subject: UMLS:C5448024

subject_name: SAF 189s

object_name: non-small cell lung carcinoma


subject: UMLS:C5448024

object_name: Advanced cancer


subject: UMLS:C5448024

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:174615

object_name: Measurable Residual Disease Negativity


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:4911

subject_name: Etoposide


subject: UMLS:C1568660

object_name: mantle cell lymphoma


subject: CHEBI:85993

subject_name: Palbociclib


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: colorectal cancer


subject: UNII:768FW21J3L

object_name: colorectal carcinoma


subject: UNII:768FW21J3L

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:3139

subject_name: bleomycin

object_name: Stomach cancer


subject: CHEBI:3139

object_name: gastric cancer


subject: UNII:U946SH95EE

subject_name: Milk thistle

object_name: end stage renal failure


subject: UNII:U946SH95EE

object_name: Chronic uremia


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:44915

subject_name: Propofol

object_name: Sedative overdose


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:188719

subject_name: Ertugliflozin

object_name: hypertension


subject: CHEBI:188719

object_name: Hypertension, CTCAE


subject: CHEBI:149504

object_name: Locally Advanced Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:149504

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:149504

object_name: Locally Advanced Pancreatic Ductal Adenocarcinoma


subject: CHEBI:149504

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:149504

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:149504

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:149504

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: UNII:4D28EY0L5T

subject_name: Dasotraline

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UNII:4D28EY0L5T


subject: PUBCHEM.COMPOUND:577181

subject_name: norsertraline


subject: PUBCHEM.COMPOUND:577181


subject: CHEBI:194146

object_name: melanoma


subject: PUBCHEM.COMPOUND:184196

object_name: Metastatic Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:184196

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C4048807


subject: UMLS:C4048807


subject: CHEBI:167672

subject_name: Tovorafenib

object_name: low grade glioma


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:49165

object_name: Atopic rhinitis


subject: CHEBI:25805

subject_name: oxygen atom

object_name: migraine


subject: CHEBI:25805

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Advanced Gastric Adenocarcinoma


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: ulcerative colitis


subject: CHEBI:73678

object_name: bacterial infectious disease


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:39867

subject_name: Valproic acid

object_name: Partial Seizure


subject: UMLS:C0305852

subject_name: Depakote Sprinkle Capsules


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: skin sarcoma


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Cirrhosis


subject: CHEBI:9150

object_name: esophageal varices with bleeding


subject: CHEBI:9150

object_name: portal vein thrombosis


subject: CHEBI:9150

object_name: Portal Vein Thrombosis, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: Chronic cough


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: RXCUI:577093

subject_name: metformin / pioglitazone Oral Tablet

object_name: Androgen excess


subject: UMLS:C5447427

subject_name: Anti-CFH Monoclonal Antibody GT103

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UMLS:C5447427

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: UMLS:C5447427

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C5447427

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:62823

subject_name: Bromothalonil

object_name: allergic contact dermatitis


subject: CHEBI:181553

subject_name: Parthenolide


subject: RXCUI:617296

subject_name: amoxicillin 500 MG / clavulanate 125 MG Oral Tablet

object_name: pulmonary tuberculosis


subject: CHEBI:3535

subject_name: Cephalexin


subject: CHEBI:3534


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: body weight


subject: UMLS:C1099192


subject: UMLS:C5855519

subject_name: Fluorine F 18 FAPI-74


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: Dyspnea caused by SARS-CoV-2


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Femur fracture


subject: PUBCHEM.COMPOUND:122662787

subject_name: BEXICASERIN

object_name: genetic developmental and epileptic encephalopathy


subject: PUBCHEM.COMPOUND:122662787

object_name: developmental and epileptic encephalopathy


subject: PUBCHEM.COMPOUND:122662787

object_name: Lennox-Gastaut syndrome


subject: PUBCHEM.COMPOUND:122662787

object_name: Dravet syndrome


subject: PUBCHEM.COMPOUND:122662787

object_name: developmental and epileptic encephalopathy, 6A


subject: DRUGBANK:DB18885

subject_name: Bexicaserin


subject: DRUGBANK:DB18885


subject: DRUGBANK:DB18885


subject: DRUGBANK:DB18885


subject: DRUGBANK:DB18885


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: graft versus host disease


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: CHEBI:77572

subject_name: Tranilast

object_name: scleredema adultorum


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: lumbar spinal stenosis


subject: UMLS:C4086546

object_name: spinal stenosis


subject: UMLS:C4086546

object_name: lumbar disc herniation


subject: UMLS:C4086546

object_name: Lumbar spondylolisthesis


subject: UMLS:C4086546

object_name: lumbar disk disease


subject: UMLS:C4086546

object_name: lumbar disk degenerative disorder


subject: UMLS:C1134570

subject_name: Recombinant Fowlpox-TRICOM Vaccine

object_name: prostate carcinoma


subject: UMLS:C1134570

object_name: prostate cancer


subject: MESH:C439566

subject_name: rV-Tricom


subject: MESH:C439566


subject: UMLS:C3666776

subject_name: Astagraf XL

object_name: end stage renal failure


subject: UMLS:C3666776

object_name: Chronic uremia


subject: UMLS:C5555042

subject_name: Danvilostomig

object_name: Childhood Breast Carcinoma


subject: UMLS:C5555042

object_name: breast carcinoma


subject: UMLS:C5555042

object_name: breast cancer


subject: CHEBI:5103

subject_name: Flumazenil

object_name: hypersomnia


subject: CHEBI:5103

object_name: Hypersomnia, CTCAE


subject: CHEBI:5103

object_name: idiopathic hypersomnia


subject: CHEBI:5103

object_name: narcolepsy without cataplexy


subject: CHEBI:5103

object_name: recurrent hypersomnia


subject: CHEBI:132082

subject_name: Entinostat

object_name: non-small cell lung carcinoma


subject: UNII:3JGY52XJNA

subject_name: Lutropin alfa

object_name: Acquired Hypogonadotropic Hypogonadism


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Unresectable Hepatocellular Carcinoma


subject: UMLS:C4527368

subject_name: ATM Inhibitor M 3541

object_name: Solid Neoplasm


subject: CHEBI:23359

subject_name: colchicine

object_name: Non ST segment elevation myocardial infarction


subject: CHEBI:23359

object_name: ST-elevation myocardial infarction


subject: CHEBI:23359

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:23359

object_name: angina unstable


subject: CHEBI:77590

subject_name: Armodafinil

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:77590

object_name: Obesity, CTCAE


subject: CHEBI:77590

object_name: Premature recovery from anaesthesia


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: GTOPDB:2943

subject_name: secretin

object_name: pancreatic neoplasm


subject: GTOPDB:2943

object_name: malignant pancreatic neoplasm


subject: GTOPDB:2943

object_name: Sturge-Weber syndrome


subject: GTOPDB:2943

object_name: Peutz-Jeghers syndrome


subject: CHEBI:232390


subject: CHEBI:232390


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: preeclampsia


subject: CHEBI:39548

object_name: cardiomyopathy


subject: CHEBI:39548

object_name: myocardial ischemia


subject: CHEBI:39548

object_name: myocardial disorder


subject: CHEBI:15414

subject_name: Adomet

object_name: Tabagism


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:23965

subject_name: estradiol

object_name: Injury of musculoskeletal system


subject: CHEBI:23965

object_name: hypogonadism


subject: CHEBI:5523

subject_name: Goserelin


subject: UMLS:C2348756

subject_name: Testosterone Gel


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: melanoma


subject: CHEBI:68646

object_name: thymoma type B3


subject: CHEBI:68646

object_name: malignant soft tissue neoplasm


subject: CHEBI:68646

object_name: sarcoma


subject: CHEBI:68646

object_name: type C thymoma


subject: CHEBI:68646

object_name: thymoma type B2


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Caesarean section


subject: CHEBI:76209

subject_name: SODIUM SULFIDE

object_name: kidney failure


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: T-cell lymphoma refractory


subject: UNII:KXG2PJ551I

object_name: T-cell lymphoma recurrent


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:231679

subject_name: ipilimumab

object_name: metastatic colorectal cancer


subject: CHEBI:16796

subject_name: Melatonin

object_name: Feeding Intolerance


subject: CHEBI:16796

object_name: Feeding Intolerance, AE


subject: CHEBI:16796

object_name: Prematurity of fetus


subject: CHEBI:16796

object_name: Premature infant


subject: CHEBI:16796

object_name: perinatal necrotizing enterocolitis


subject: CHEBI:16796

object_name: necrotizing enterocolitis


subject: CHEBI:16796

object_name: Necrotizing Enterocolitis, AE


subject: CHEBI:9241

subject_name: Spironolactone

object_name: alcoholic cardiomyopathy


subject: CHEBI:61397

subject_name: Neratinib

object_name: liver failure


subject: UMLS:C1454298

subject_name: HKI 272


subject: CHEBI:68551

subject_name: Linaclotide

object_name: Gastrointestinal hemorrhage


subject: CHEBI:68551

object_name: ulcerative colitis


subject: CHEBI:68551

object_name: inflammatory bowel disease 1


subject: CHEBI:68551

object_name: Crohn disease


subject: CHEBI:50733

subject_name: nutraceutical

object_name: spastic cerebral palsy


subject: CHEBI:25017

subject_name: leucine


subject: UMLS:C5854369

subject_name: Site Specific Immunomodulator QBECO

object_name: inflammatory bowel disease


subject: UMLS:C2987455

subject_name: CHP-NY-ESO-1 Peptide Vaccine IMF-001

object_name: carcinoma of esophagus


subject: UMLS:C2987455

object_name: esophageal cancer


subject: UMLS:C2987455

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C2987455

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:156963194

subject_name: 17-hydroxyprogesterone caproate

object_name: pregnancy disorder


subject: UMLS:C1831890

object_name: non-small cell lung carcinoma


subject: CHEBI:151315

subject_name: Heparin

object_name: Thrombophilia associated with pregnancy


subject: CHEBI:151315


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Nonvalvular atrial fibrillation


subject: GTOPDB:13692

subject_name: mitazalimab

object_name: pancreatic ductal adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297870

subject_name: MITAZALIMAB


subject: UMLS:C4053684


subject: DRUGBANK:DB17468

subject_name: Odetiglucan


subject: UNII:96265TNH2R

subject_name: Gedatolisib

object_name: Childhood Breast Carcinoma


subject: UNII:96265TNH2R

object_name: breast carcinoma


subject: UNII:96265TNH2R

object_name: breast cancer


subject: CHEBI:135207

subject_name: Clofedanol

object_name: cardiovascular disorder


subject: CHEBI:135207

object_name: Hemorrhage


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: periodontitis, chronic, adult


subject: CHEBI:2567

object_name: chronic periodontitis


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: uveitis


subject: UNII:7D0YB67S97

object_name: Uveitis, CTCAE


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:189653

subject_name: pelabresib

object_name: plasma cell myeloma


subject: UMLS:C2826163

subject_name: MUC1 Peptide-Poly-ICLC Vaccine

object_name: colorectal adenoma


subject: UMLS:C2826163

object_name: colorectal carcinoma


subject: UMLS:C2826163

object_name: Colorectal Adenoma with Severe Dysplasia


subject: UMLS:C2826163

object_name: colorectal tubulovillous adenoma


subject: UMLS:C0004149

subject_name: ATGAM


subject: UMLS:C0004149

object_name: amyloidosis


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:51041

subject_name: Acamprosate

object_name: Gambling


subject: MESH:C000709231


subject: MESH:C000709231


subject: MESH:C000709231


subject: MESH:C000709231

object_name: Carcinoma breast stage IV


subject: MESH:C000709231

object_name: thyroid tumor


subject: MESH:C000709231

object_name: thyroid gland carcinoma


subject: MESH:C000709231

object_name: thyroid cancer


subject: MESH:C000709231

object_name: small cell lung carcinoma


subject: MESH:C000709231

object_name: non-small cell lung carcinoma


subject: MESH:C000709231

object_name: glioblastoma


subject: MESH:C000709231

object_name: Brain Stem Glioblastoma


subject: MESH:C000709231

object_name: glioma susceptibility 1


subject: MESH:C000709231


subject: MESH:C000709231

object_name: nonpapillary renal cell carcinoma


subject: MESH:C000709231

object_name: clear cell renal carcinoma


subject: MESH:C000709231

object_name: renal cell adenocarcinoma


subject: MESH:C000709231

object_name: renal cell carcinoma


subject: MESH:C000709231

object_name: non-Hodgkin lymphoma


subject: MESH:C000709231

object_name: Hodgkin Disease


subject: MESH:C000709231

object_name: pediatric osteosarcoma


subject: MESH:C000709231

object_name: Osteosarcoma


subject: MESH:C000709231

object_name: leukemia


subject: MESH:C000709231

object_name: childhood leukemia


subject: MESH:C000709231

object_name: adult lymphoma


subject: MESH:C000709231

object_name: lymphoma


subject: MESH:C000709231

object_name: pediatric lymphoma


subject: MESH:C000709231

object_name: melanoma


subject: MESH:C000709231

object_name: malignant soft tissue neoplasm


subject: MESH:C000709231

object_name: sarcoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: breast cancer


subject: PUBCHEM.COMPOUND:1805

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:1805

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:1805

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: thyroid cancer


subject: PUBCHEM.COMPOUND:1805

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:1805

object_name: Brain Stem Glioblastoma


subject: PUBCHEM.COMPOUND:1805

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:1805

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: renal cell adenocarcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: UMLS:C3273554


subject: UMLS:C5814320

subject_name: Recombinant human arylsulfatase A

object_name: metachromatic leukodystrophy, late infantile form


subject: UMLS:C5814320

object_name: metachromatic leukodystrophy, juvenile form


subject: CHEBI:16796

subject_name: Melatonin

object_name: cardiomyopathy


subject: CHEBI:135702

subject_name: Belotecan

object_name: cervical cancer


subject: CHEBI:135702

object_name: cervical carcinoma


subject: UMLS:C0762739

subject_name: CKD 602


subject: UMLS:C0762739


subject: UMLS:C5552902

subject_name: Anti-interleukin-1 Beta Monoclonal Antibody FL-101

object_name: Muscle Invasive Bladder Carcinoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: psoriasis


subject: PUBCHEM.COMPOUND:24755620

subject_name: Sacubitril valsartan

object_name: essential hypertension


subject: UNII:688RNR55GH

subject_name: SACUBITRIL VALSARTAN


subject: UMLS:C4033631

subject_name: sacubitril / valsartan


subject: UMLS:C2826381

object_name: cancer


subject: UMLS:C2826381


subject: CHEBI:90225

subject_name: Rubitecan

object_name: malignant soft tissue neoplasm


subject: CHEBI:90225

object_name: sarcoma


subject: CHEBI:90225

object_name: Plexosarcoma


subject: CHEBI:90225

object_name: small intestine cancer


subject: CHEBI:90225

object_name: small intestine carcinoma


subject: CHEBI:3441

subject_name: Carvedilol

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:3441

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:3441

object_name: Malignant Solid Neoplasm


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: pulmonary hypertension


subject: CHEBI:3614

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:3614

object_name: Pulmonary heart disease and diseases of pulmonary circulation (I26-I28)


subject: CHEBI:3614

object_name: Heart failure with normal ejection fraction


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Small cell glioblastoma


subject: CHEBI:231614

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:231614

object_name: Childhood Giant Cell Glioblastoma


subject: CHEBI:231614

object_name: giant cell glioblastoma


subject: CHEBI:231614

object_name: glioma susceptibility 1


subject: CHEBI:231614

object_name: adult oligodendroglioma


subject: CHEBI:231614

object_name: oligodendroglioma


subject: CHEBI:231614

object_name: childhood oligodendroglioma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C4055082

subject_name: East Indian Sandalwood Oil Mouth Rinse

object_name: Oral Mucositis


subject: UMLS:C4055082

object_name: stomatitis


subject: UMLS:C4055082

object_name: oral mucositis


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: chronic thromboembolic pulmonary hypertension


subject: CHEBI:51450

subject_name: Bosentan


subject: UMLS:C4086732

subject_name: ANF-Rho

object_name: Chemotherapy induced neutropenia


subject: CHEBI:50861

subject_name: Treprostinil

object_name: congenital heart disease


subject: PUBCHEM.COMPOUND:44210114

subject_name: Lurasidone

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:44210114

object_name: autism


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:5470

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:5470

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:5470

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: CHEBI:68579

object_name: Poisoning by, adverse effect of and underdosing of anticoagulants


subject: CHEBI:68579

object_name: Poisoning by anticoagulant


subject: CHEBI:68579

object_name: aortic valve disease 1


subject: CHEBI:68579

object_name: Aortic Valve Disease, CTCAE


subject: CHEBI:78432

subject_name: Ceritinib

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:78432

object_name: stage IV pancreatic cancer


subject: CHEBI:78432

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:78432

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:78432

object_name: Pancreatic carcinoma stage III


subject: CHEBI:78432

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:78432

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:78432

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:78432

object_name: ALK Positive


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:9815560

subject_name: Estreptoquinasa

object_name: acute pancreatitis


subject: UNII:8X1OXL3SNU

subject_name: STREPTOKINASE


subject: UMLS:C0038418

subject_name: streptokinase


subject: UMLS:C1327951

object_name: Recurrent ovarian cancer


subject: UMLS:C1327951

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: CHEBI:77733

subject_name: Verapamil

object_name: osteoarthritis, knee


subject: CHEBI:8988

object_name: Colorectal cancer recurrent


subject: CHEBI:80630

subject_name: Irinotecan


subject: UMLS:C5417747

subject_name: Maackia amurensis Seed Lectin

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: systolic heart failure


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate

object_name: alopecia universalis congenita


subject: CHEBI:135765

object_name: alopecia areata 1


subject: CHEBI:135765

object_name: alopecia universalis


subject: CHEBI:135765

object_name: alopecia totalis


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: UMLS:C5435279

subject_name: cabenuva

object_name: opiate dependence


subject: UMLS:C5435279

object_name: HIV infection


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE


subject: UMLS:C0453273

subject_name: cranberry preparation

object_name: Burn injury


subject: UMLS:C0453273

object_name: Burn, CTCAE


subject: CHEBI:81569

subject_name: Follitropin

object_name: Kallmann syndrome


subject: UMLS:C0016774

subject_name: Human Follicle-Stimulating Hormone


subject: UMLS:C0016774

object_name: hypogonadism


subject: GTOPDB:4386

subject_name: FSH


subject: GTOPDB:4386


subject: UMLS:C0016424

subject_name: Follicle stimulating hormone injectable


subject: UMLS:C0016424


subject: CHEBI:8382

subject_name: Prednisone

object_name: graft versus host disease


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Rheumatism


subject: CHEBI:31300

object_name: connective tissue disorder


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: CHEBI:15365

subject_name: Aspirin

object_name: carotid artery disorder


subject: CHEBI:37941

subject_name: Clopidogrel


subject: PUBCHEM.COMPOUND:2269

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:2269

object_name: acute chest syndrome


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UMLS:C5447779

subject_name: Axl/Mer/CSF1R Inhibitor Q702

object_name: cervical cancer


subject: UMLS:C5447779

object_name: cervical carcinoma


subject: UMLS:C5447779

object_name: carcinoma of esophagus


subject: UMLS:C5447779

object_name: esophageal cancer


subject: UMLS:C5447779

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5447779

object_name: neoplasm of esophagus


subject: UMLS:C5447779

object_name: adult hepatocellular carcinoma


subject: UMLS:C5447779

object_name: liver cancer


subject: UMLS:C5447779

object_name: pediatric hepatocellular carcinoma


subject: UMLS:C5447779

object_name: liver carcinoma


subject: UMLS:C5447779

object_name: Stomach cancer


subject: UMLS:C5447779

object_name: gastric cancer


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Mechanical ventilation finding


subject: UMLS:C0059079

subject_name: EMLA

object_name: melanoma


subject: UMLS:C0059079

object_name: skin melanoma


subject: UMLS:C0059079

object_name: skin squamous cell carcinoma


subject: UMLS:C0059079

object_name: trabecular adenocarcinoma


subject: UMLS:C0059079

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor


subject: CHEBI:49200


subject: CHEBI:49200

object_name: Drug usage


subject: CHEBI:49200

object_name: Drug use history


subject: CHEBI:49200

object_name: Encounter due to drug use


subject: CHEBI:49200


subject: CHEBI:49200


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors

object_name: carcinoma of esophagus


subject: UMLS:C0358591

object_name: esophageal cancer


subject: UMLS:C0358591


subject: UMLS:C0358591


subject: UMLS:C0358591


subject: UMLS:C0358591


subject: UMLS:C0358591


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: UMLS:C3536754


subject: UMLS:C3536754


subject: UMLS:C3536754


subject: UMLS:C3536754


subject: UMLS:C3536754


subject: UMLS:C3536754


subject: CHEBI:41060

subject_name: IBANDRONATE

object_name: Childhood Breast Carcinoma


subject: CHEBI:41060

object_name: breast carcinoma


subject: CHEBI:41060

object_name: breast cancer


subject: UNII:UMD7G2653W

subject_name: Ibandronate


subject: UNII:UMD7G2653W


subject: UNII:UMD7G2653W


subject: CHEBI:157881

subject_name: Pro-Cys

object_name: postmenopausal disorder


subject: CHEBI:157881

object_name: Hypercholesterolemia


subject: CHEBI:157881

object_name: osteoporosis


subject: CHEBI:157881

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:157881

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:157881

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:73648

subject_name: Pro-Ser


subject: CHEBI:73648


subject: CHEBI:73648


subject: CHEBI:73648


subject: CHEBI:73648


subject: CHEBI:73648


subject: CHEBI:30224

subject_name: positronium


subject: CHEBI:30224


subject: CHEBI:30224


subject: CHEBI:30224


subject: CHEBI:30224


subject: CHEBI:30224


subject: CHEBI:53276

subject_name: poly(styrene)


subject: CHEBI:53276


subject: CHEBI:53276


subject: CHEBI:53276


subject: CHEBI:53276


subject: CHEBI:53276


subject: CHEBI:18303


subject: CHEBI:18303


subject: CHEBI:18303


subject: CHEBI:18303


subject: CHEBI:18303


subject: CHEBI:18303


subject: PR:000023489

subject_name: pantothenate synthetase


subject: PR:000023489


subject: PR:000023489


subject: PR:000023489


subject: PR:000023489


subject: PR:000023489


subject: GTOPDB:13658

subject_name: olezarsen

object_name: familial lipoprotein lipase deficiency


subject: GTOPDB:13658

object_name: familial chylomicronemia syndrome


subject: CHEMBL.COMPOUND:CHEMBL4650438

subject_name: OLEZARSEN


subject: CHEMBL.COMPOUND:CHEMBL4650438


subject: CHEBI:42797

subject_name: Gabapentin

object_name: carpal tunnel syndrome 1


subject: CHEBI:42797

object_name: carpal tunnel syndrome


subject: CHEBI:229764

subject_name: Selinexor

object_name: Plasma cell myeloma refractory


subject: CHEBI:119915

subject_name: Fentanyl

object_name: herpes zoster


subject: CHEBI:119915

object_name: postherpetic neuralgia


subject: CHEBI:119915

object_name: complex regional pain syndrome


subject: PUBCHEM.COMPOUND:14326905

object_name: IDH-wildtype glioblastoma


subject: UNII:3HX21A3SQF

subject_name: Ropidoxuridine


subject: MESH:C433226

subject_name: twinrix

object_name: hepatitis A


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: aspergillosis


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin


subject: UMLS:C0879264


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Anterior Cruciate Ligament Injuries


subject: CHEBI:32712

subject_name: L-tryptophanyl radical

object_name: post-traumatic stress disorder


subject: CHEBI:32712

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:32712

object_name: Depressive Symptoms


subject: CHEBI:29954

subject_name: L-tryptophan residue


subject: CHEBI:29954


subject: CHEBI:29954


subject: CHEBI:27897

subject_name: tryptophan


subject: CHEBI:27897


subject: CHEBI:27897


subject: CHEBI:231369

subject_name: Savolitinib

object_name: lung cancer


subject: CHEBI:231369

object_name: lung neoplasm


subject: CHEBI:231369

object_name: lung carcinoma


subject: CHEBI:16899

subject_name: Mannitol

object_name: asthma


subject: CHEBI:25805

subject_name: oxygen atom

object_name: cluster headache syndrome


subject: CHEBI:15379

subject_name: Oxygen


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Hermansky-Pudlak syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: hepatopulmonary syndrome


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: neurofibromatosis


subject: CHEBI:72317

object_name: neurofibromatosis 1


subject: CHEBI:72317

object_name: neurofibroma


subject: CHEBI:72317

object_name: neurofibromatosis type 1


subject: CHEBI:72317

object_name: plexiform neurofibroma


subject: UNII:OS7097575K

subject_name: Parsaclisib

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:17753757

subject_name: Pimecrolimus

object_name: discoid lupus erythematosus


subject: PUBCHEM.COMPOUND:17753757

object_name: cutaneous lupus erythematosus


subject: UMLS:C0003438

subject_name: antithrombin III

object_name: Acquired antithrombin III deficiency


subject: UMLS:C0724532

subject_name: antithrombin III, human


subject: UMLS:C0723738

subject_name: Thrombate III


subject: UMLS:C4764390

subject_name: Intuvax

object_name: Plexosarcoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Embolism, Tumor


subject: CHEBI:60802

object_name: Neoplasm Metastasis


subject: CHEBI:60802

object_name: Metastasis


subject: CHEBI:60802

object_name: Metastatic Lesion


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: acute respiratory distress syndrome


subject: UNII:XRO4566Q4R

object_name: acute lung injury


subject: UNII:XRO4566Q4R

object_name: adult acute respiratory distress syndrome